If approved, it would be the first vaccine given to expectant mothers to protect against the disease, currently the leading cause of hospitalizations for infants.
A vaccine to protect against severe cases of Respiratory Syncytial Virus could roll out as early as August.
The FDA is expected to make their decision in August — just before respiratory virus season comes out in full force. If approved, it would be the first vaccine given to expectant mothers to protect against the disease in infants from birth through their first six months. “If approved, RSVpreF would help protect infants at their first breath from the devastating effects of this infectious disease, which though well-known, has been particularly evident throughout this RSV season,” Annaliesa Anderson, Pfizer’s chief scientific officer of vaccine research and development, said in a“We look forward to progressing the review of Pfizer’s RSV maternal vaccine candidate with the FDA and other regulatory authorities, given its significant potential to positively...
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
1st RSV vaccine could be approved by August, pending FDA reviewThe FDA will decide whether or not to approve an RSV vaccine designed to protect newborns by August 2023.
Consulte Mais informação »
1st RSV vaccine could be approved by August, pending FDA reviewPfizer's vaccine would be the first RSV vaccine given to pregnant people to protect infants. The company said that there were 'no safety concerns' for vaccinated pregnant participants and their newborns during the trial.
Consulte Mais informação »
1st RSV vaccine could be approved by August, pending FDA reviewPfizer's vaccine would be the first RSV vaccine given to pregnant people to protect infants. The company said that there were 'no safety concerns' for vaccinated pregnant participants and their newborns during the trial.
Consulte Mais informação »
First Mover Americas: BNB-Bitcoin Ratio Falls to Lowest Level Since August$BNB coin is falling relative to bitcoin and FTX_Official bankruptcy claims are being snapped up for $0.20 on the dollar. JamieCrawleyCD reports
Consulte Mais informação »
Pfizer RSV Vaccine That Protects Infants Could Receive FDA Approval This SummerThe single-dose RSV vaccine developed by Pfizer is administered to expectant mothers in the late second-to-third trimester of their pregnancy.
Consulte Mais informação »
1st RSV vaccine could be approved this summerAfter decades of research, a first-of-its kind vaccine designed to protect newborns against RSV, or respiratory syncytial virus, could be approved by August.
Consulte Mais informação »